Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Julphar
Mallinckrodt
McKinsey
Queensland Health
Deloitte

Generated: August 19, 2019

DrugPatentWatch Database Preview

Patent: 8,449,886

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,449,886
Title:Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases
Abstract: Compositions and methods are disclosed which are useful for the treatment and prevention of proliferative disorders, and which comprise an anti-CTLA4 antagonist with a tubulin modulating agent.
Inventor(s): Jure-Kunkel; Maria (Plainsboro, NJ)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:12/811,867
Patent Claims:see list of patent claims

Details for Patent 8,449,886

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb YERVOY ipilimumab INJECTABLE; INJECTION 125377 001 2011-03-25   Try a Free Trial Bristol-Myers Squibb Company (Princeton, NJ) 2028-01-08 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,449,886

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2009089260 Dec 03, 2009
World Intellectual Property Organization (WIPO) 2009089260 Jul 16, 2009
United States of America 2010278828 Nov 04, 2010
South Korea 20100100949 Sep 15, 2010
Japan 2011509299 Mar 24, 2011
Spain 2558568 Feb 05, 2016
European Patent Office 2227296 Nov 25, 2015
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Merck
Baxter
Healthtrust
Daiichi Sankyo
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.